When did Lifecore Biomedical, Inc. report Q2 2026 earnings?

Lifecore Biomedical, Inc. (LFCR) reported Q2 2026 earnings on November 6, 2025 after market close.

What were Lifecore Biomedical, Inc.'s Q2 2026 revenue and EPS?

Lifecore Biomedical, Inc. reported revenue of $31.1M and eps of $-0.29 for Q2 2026.

Did Lifecore Biomedical, Inc. beat estimates in Q2 2026?

Revenue beat the consensus estimate of $26.5M by $4.6M. EPS beat the consensus estimate of $-0.30 by $0.01.

Where can I find Lifecore Biomedical, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001005286-25-000146) and the 10-Q periodic report (0001005286-25-000148) directly on SEC EDGAR. The filing index links above go to sec.gov.

Lifecore Biomedical, Inc. LFCR Q2 2026 earnings

Reported November 6, 2025 · After market close

Revenue$31.1MBeat by $4.6M

EPS-$0.29Beat by $0.01

Revenue estimate$26.5M

EPS estimate-$0.30

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$33.1M

EPS estimate-$0.22

Financials

Q2 2026

Income statement

See full

Revenue$31.1M-4.5%

Gross profit$7.8M-29.7%

Operating income-$3.1M-56.6%

Net income-$10.0M-52.0%

EPS (diluted)-$0.29-16.0%

Balance sheet

See full

Cash & equivalents$18.9M+99.4%

Total debt$8.4M-92.4%

Total equity-$10.5M-168%

Total assets$235.2M-7.9%

Cash flow

See full

Operating cash flow$1.8M+129%

CapEx$1.7M-28.8%

Free cash flow$25.0K+100%

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$295.98M+29.5%

Enterprise value$285.57M-13.6%

Returns & leverage

See full

Current ratio2.8×+0.5×

Segments

By product

See full

CDMO$21.7M-15.1%

HA manufacturing$9.4M+34.6%

By segment

See full

Reportable Segment$31.1M—

Versus estimates

Revenue

Q3 2027$23.2MMiss by $2.8M Q3 2026$35.2MBeat by $2.0M

Q2 2026$31.1MBeat by $4.6M

Q4 2025$36.4MBeat by $11.2M Q3 2025$35.2MMiss by $209.3K

Diluted EPS

Q3 2027-$0.43Miss by $0.14 Q4 2026-$0.43Miss by $0.19 Q3 2026-$0.16Beat by $0.11

Q2 2026-$0.29Beat by $0.01

Q4 2025-$0.10Miss by $0.01 Q3 2025-$0.19Miss by $0.05

Ask the moment Lifecore Biomedical, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Lifecore Biomedical, Inc. report Q2 2026 earnings?: Lifecore Biomedical, Inc. (LFCR) reported Q2 2026 earnings on November 6, 2025 after market close.
What were Lifecore Biomedical, Inc.'s Q2 2026 revenue and EPS?: Lifecore Biomedical, Inc. reported revenue of $31.1M and eps of $-0.29 for Q2 2026.
Did Lifecore Biomedical, Inc. beat estimates in Q2 2026?: Revenue beat the consensus estimate of $26.5M by $4.6M. EPS beat the consensus estimate of $-0.30 by $0.01.
Where can I find Lifecore Biomedical, Inc.'s Q2 2026 SEC filings?: You can read the 8-K earnings release (0001005286-25-000146) and the 10-Q periodic report (0001005286-25-000148) directly on SEC EDGAR. The filing index links above go to sec.gov.